RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
Superinvestors holding RDHL, Q2 2026
No superinvestor reported holding RDHL in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RDHL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2022
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q2 2022
1 superinvestor holding at quarter end
- Added
- ARK Invest (+21.3%)
Q1 2022
1 superinvestor holding at quarter end
- New
- ARK Invest
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- ARK Invest
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- ARK Invest (−97.6%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- ARK Invest (+1.5%)